ASP Isotopes Inc. (NASDAQ: ASPI) announced today that it has priced an underwritten public offering of 17,167,380 shares of its common stock, generating total gross proceeds of approximately $210.3 million before underwriting discounts and commissions.
The offering, managed by Cantor and Lucid Capital Markets as joint book‑running managers, is expected to close on October 16, 2025. All shares in the offering will be sold by the company, and the underwriters have a 30‑day option to purchase an additional $31.5 million of shares at the offering price.
This pricing follows the company’s earlier announcement on October 14, 2025 of the commencement of the public offering. The proceeds will be used for general corporate purposes, including working capital, operating expenses, and capital expenditures, positioning ASP Isotopes to support its expansion of isotope production facilities and strategic initiatives.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.